We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.02B
AUM Growth
+$915M
(+22%)
Cap. Flow
+$807M
Cap. Flow
% of AUM
16.08%
Top 10 Holdings %
Top 10 Hldgs %
23.32%
Holding
1,875
New
492
Increased
516
Reduced
411
Closed
433
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$152M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$127M |
| 3 |
AABA
Altaba Inc
AABA
|
+$120M |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$78.4M |
| 5 |
ALR
Alere Inc
ALR
|
+$59.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$104M |
| 2 |
OKS
Oneok Partners LP
OKS
|
+$86.4M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$84.7M |
| 4 |
SWC
Stillwater Mining Co
SWC
|
+$50.9M |
| 5 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$38.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Healthcare | 13.87% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Industrials | 11.63% |
| 5 | Energy | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KIN
1401
DELISTED
Kindred Biosciences, Inc.
KIN
| $128K | ﹤0.01% |
+14,937
| New | +$107K |
|
1402
Simulations Plus
SLP
$371M
| $126K | ﹤0.01% |
+10,205
| New | +$121K |
|
|
CVO
1403
DELISTED
Cenevo, Inc.
CVO
| $126K | ﹤0.01% |
20,716
-11,750
| -36% | -$61.3K |
|
|
PRGX
1404
DELISTED
PRGX Global, Inc.
PRGX
| $123K | ﹤0.01% |
18,858
+8,063
| +75% | +$51.8K |
|
|
IO
1405
DELISTED
ION Geophysical Corporation
IO
| $123K | ﹤0.01% |
28,265
-21,114
| -43% | -$92.4K |
|
1406
EyePoint Inc
EYPT
$1.03B
| $118K | ﹤0.01% |
+6,900
| New | +$131K |
|
1407
Friedman Industries
FRD
$246M
| $118K | ﹤0.01% |
20,769
-299
| -1% | -$1.74K |
|
1408
Curis
CRIS
$9.9M
| $115K | ﹤0.01% |
+30
| New | +$125K |
|
1409
Digi International
DGII
$2.65B
| $108K | ﹤0.01% |
+10,673
| New | +$113K |
|
1410
LifeVantage
LFVN
$81.5M
| $105K | ﹤0.01% |
24,353
-29,410
| -55% | -$130K |
|
|
MCBC
1411
DELISTED
Macatawa Bank Corp
MCBC
| $103K | ﹤0.01% |
10,775
-1,872
| -15% | -$17.9K |
|
|
CDTX
1412
DELISTED
Cidara Therapeutics
CDTX
| $98K | ﹤0.01% |
+656
| New | +$90.7K |
|
1413
QuinStreet
QNST
$905M
| $98K | ﹤0.01% |
+23,460
| New | +$94.2K |
|
|
TI
1414
DELISTED
Telecom Italia
TI
| $96K | ﹤0.01% |
10,268
-26
| -0.3% | -$241 |
|
|
CYTR
1415
DELISTED
CytRx Corp
CYTR
| $94K | ﹤0.01% |
+25,016
| New | +$85.5K |
|
|
GARS
1416
DELISTED
Garrison Capital Inc.
GARS
| $93K | ﹤0.01% |
+11,265
| New | +$102K |
|
1417
Codexis
CDXS
$158M
| $88K | ﹤0.01% |
16,136
-1,447
| -8% | -$6.66K |
|
|
AIFU
1418
AIFU Inc
AIFU
$213M
| $87K | ﹤0.01% |
25
-113
| -82% | -$393K |
|
1419
Polar Power
POLA
$6.63M
| $86K | ﹤0.01% |
+2,317
| New | +$95.3K |
|
1420
Aptevo Therapeutics
APVO
$4.9M
| – | – |
0
| – | – |
|
|
TRIB
1421
Trinity Biotech
TRIB
$7.57M
| $78K | ﹤0.01% |
87
-211
| -71% | -$179K |
|
|
ALJJ
1422
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $78K | ﹤0.01% |
+24,262
| New | +$81.1K |
|
|
SRGA
1423
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $78K | ﹤0.01% |
442
+86
| +24% | +$12.2K |
|
1424
MannKind Corp
MNKD
$1.19B
| $76K | ﹤0.01% |
+54,243
| New | +$69.8K |
|
1425
SiriusXM
SIRI
$10.3B
| $69K | ﹤0.01% |
+1,259
| New | +$64.3K |
|
Similar funds
5SA
KG
BCM
VOMP
TLA
RWS
SC
RWMG
Oxford Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oxford Asset Management held 1,875 positions worth $5.02B, up 22% from $4.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oxford Asset Management deployed $807M of net new capital in Q2 2017, opening 492 new positions and adding to 516 existing holdings. Its largest new stake was CR Bard Inc.: 511,170 shares worth $162M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $32M trimmed.
- Oxford Asset Management's largest Q2 2017 buy was CR Bard Inc.: 511,170 shares worth $162M.
- Oxford Asset Management added most to Rice Energy Inc. in Q2 2017, an estimated $127M increase.
- Oxford Asset Management's biggest Q2 2017 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32M.
- Oxford Asset Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $104M.
- Oxford Asset Management's ten largest holdings make up 23% of its $5.02B portfolio in Q2 2017.
- Oxford Asset Management opened 492 new positions and closed 433 in Q2 2017.
- Oxford Asset Management's portfolio value rose 22% quarter-over-quarter to $5.02B.
Based on Oxford Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.